In this study, we set up a SOR-resistant cell model and conducted a significant investigation into the correlation between SOR resistance and miR-92b expression, demonstrating that miR-92b/PTEN axis can regulate SOR sensitivity of HCC cells via the PI3K/AKT/mTOR signaling pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.